Physician profile

Aravind Arepally

Vascular & Interventional Radiology · Atlanta, GA

NPI 1275597130

$248,702.10

in general payments reported to CMS, 2019-2025

17 companies · $839 in 2025

The $839 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$6,500.00
Food and Beverage$2,860.22
Travel and Lodging$1,073.02

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Trisalus Life Sciences, INC. $154,541.06 2019-2025 Trinav Infusion System
Siemens Medical Solutions USA, INC. $47,634.36 2021-2024
Biocompatibles, INC. $18,738.97 2019
W. L. Gore & Associates, INC. $15,234.86 2019-2025 Gore Viabahn Endoprosthesis, Viatorr Endoprosthesis, Gore Viatorr Tips Endoprosthesis
Varian Medical Systems, INC. $8,640.00 2020-2021
Boston Scientific Corporation $1,344.67 2019-2024 Therasphere Y90 Glass Microspheres 10 Gbq, Embold Fibered
Delcath Systems $1,130.76 2024-2025 Hepzato Kit, Hepzato Kit
Medtronic, INC. $329.04 2021-2022
Sirtex Medical INC $168.91 2022-2024 Sir-Spheres Microspheres
Btg International Canada INC. $149.45 2019
Penumbra, INC. $148.91 2025 Ruby Coil
Stryker Corporation $137.31 2025 Optablate
Histosonics, INC. $127.50 2024
Medtronic USA, INC. $125.16 2019
Bard Peripheral Vascular, INC. $117.74 2025 Trek
Show all 17 companies
CompanyGeneral paymentsYearsTop products
Fujifilm Healthcare Americas Corporation $111.97 2023 Utaswako Afp-L3
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $21.43 2024 Xifaxan

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Aravind Arepally

$248,702.10

in general payments reported 2019-2025

Years
2019-2025
Top company
Trisalus Life Sciences, INC.
Context
The $839 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).

https://glasscript.com/doctor/57523/aravind-arepally

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.